 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$17.59 |
$17.60 |
$17.15 |
$17.34 |
1.08M | | 04/17/2024 |
$17.38 |
$17.56 |
$16.79 |
$16.82 |
1.37M | | 04/18/2024 |
$16.72 |
$16.95 |
$16.54 |
$16.60 |
1.19M | | 04/19/2024 |
$16.50 |
$16.80 |
$15.91 |
$16.00 |
1.48M | | 04/22/2024 |
$16.00 |
$16.28 |
$15.48 |
$15.99 |
3.06M |
|
|
| Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia. | |
|
Denali Therapeutics (DNLI) has the following price history information. Looking back at DNLI historical stock prices for the last five trading days, on April 16, 2024, DNLI opened at $17.59, traded as high as $17.60 and as low as $17.15, and closed at $17.34. Trading volume was a total of 1.08M shares. On April 17, 2024, DNLI opened at $17.38, traded as high as $17.56 and as low as $16.79, and closed at $16.82. Trading volume was a total of 1.37M shares. On April 18, 2024, DNLI opened at $16.72, traded as high as $16.95 and as low as $16.54, and closed at $16.60. Trading volume was a total of 1.19M shares. On April 19, 2024, DNLI opened at $16.50, traded as high as $16.80 and as low as $15.91, and closed at $16.00. Trading volume was a total of 1.48M shares. On April 22, 2024, DNLI opened at $16.00, traded as high as $16.28 and as low as $15.48, and closed at $15.99. Trading volume was a total of 3.06M shares.
DNLI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Denali Therapeutics shares, starting with a $10,000 purchase of DNLI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/11/2017 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$20.99 |
|
| End price/share: |
$15.99 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-23.82% |
|
| Average Annual Total Return: |
-4.18% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,620.44 |
|
| Years: |
6.36 |
|
|
|
| Date |
Close |
| 04/16/2024 | $17.34 | | 04/17/2024 | $16.82 | | 04/18/2024 | $16.60 | | 04/19/2024 | $16.00 | | 04/22/2024 | $15.99 |
|
|
